Nbw Capital LLC Merck & Co., Inc. Transaction History

Nbw Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 13, 2024	BUY	$113.24 - $131.95 $339 - $395	3 Added 0.14%	2,152 $283,000
Q4 2023 Jan 31, 2024	BUY	$100.18 - $109.02 $3,907 - $4,251	39 Added 1.85%	2,149 $234,000
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $30,164 - $33,498	-293 Reduced 12.19%	2,110 $217,000
Q2 2023 Aug 15, 2023	BUY	$108.61 - $118.38 $25,740 - $28,056	237 Added 10.94%	2,403 $277,000
Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $12,970 - $14,472	-126 Reduced 5.5%	2,166 $230,000
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $200,412 - $256,956	2,292 New	2,292 $254,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Nbw Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Nbw Capital LLC with notifications on news.